These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1364373)

  • 1. [Preliminary screening for antiviral AIDS drugs. II. Report on fiscal year 1989].
    Noro S; Sato N; Sakurada N; Fujita N; Ishizaki T; Kamimura N; Yoshida Y; Ono T; Ohtomo N; Matsuda Y
    Eisei Shikenjo Hokoku; 1991; (109):107-10. PubMed ID: 1364373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preliminary screening for antiviral AIDS drugs. I. Report on fiscal year 1988].
    Miki T; Ohnuki N; Shinkai T; Yabuuchi K; Ono T; Ohtomo N; Matsuda Y; Matsuyama M; Akiyoshi K; Ohtake T
    Eisei Shikenjo Hokoku; 1990; (108):128-31. PubMed ID: 1364341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preliminary screening for antiviral AIDS drugs. III. Report on fiscal year 1990].
    Ohtake T; Mori H; Morimoto M; Ueba N; Kunita N; Matsuda Y; Matsuyama M; Akiyoshi K; Noro S; Sato N
    Eisei Shikenjo Hokoku; 1992; (110):88-91. PubMed ID: 1364446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary screening for antiviral AIDS drugs. VII. Report for fiscal year 1994].
    Ohmuki N; Kazama K; Sadamasu T; Sekine H; Ohta K; Kudoh Y; Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S; Sawada H; Kimura H; Yamada A; Ishizaki T; Kamimura N; Yoshida Y; Ono T; Tachibana N; Morishita T; Kobayashi S; Miyake T; Ishiwara Y; Ishikawa N; Moritugu Y
    Eisei Shikenjo Hokoku; 1996; (114):50-2. PubMed ID: 9037866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary screening for antiviral AIDS drugs. IV. Report on fiscal year 1991].
    Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S; Sato N; Sakurada N; Fujita N; Ishizaki T; Kamimura N
    Eisei Shikenjo Hokoku; 1993; (111):100-2. PubMed ID: 7920545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary screening for antiviral AIDS drugs. VI. Report for fiscal year 1993].
    Ushijima H; Takahashi K; Kunisada T; Moritugu Y; Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S; Sawada H; Sakurada N; Yamada A; Ishizaki T; Kamimura N; Yoshida Y; Ono T; Ohtomo N; Morishita T; Kobayashi S; Miyake T; Ishiwara Y; Suzuki R; Saito T; Etoh S; Mise K
    Eisei Shikenjo Hokoku; 1996; (114):48-9. PubMed ID: 9037865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preliminary screening for antiviral AIDS drugs. IV. Report on fiscal year 1992].
    Sekine H; Ohnuki N; Sadamasu K; Ohta K; Terayama T; Kobayashi N; Noguchi Y; Matsuyama M; Akiyoshi K; Noro S
    Eisei Shikenjo Hokoku; 1994; (112):131-3. PubMed ID: 8854914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary screening for antiviral AIDS drugs. VIII. Report for fiscal year 1995].
    Morishita T; Kobayashi S; Sato K; Sakae K; Ishikawa N; Kobayashi N; Noguchi Y; Akiyoshi K; Suga T; Ogawa A; Noro S; Sawada H; Kimura H; Yamada A; Ishizaki T; Kamimura N; Iwashima A; Ono T; Tachibana N; Sekine H; Ohnuki N; Kazama K; Sadamasu K; Ohta K; Mise K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1997; (115):152-4. PubMed ID: 9641832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT).
    Balagopala MI; Ollapally AP; Lee HJ
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S1-7. PubMed ID: 8574137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 group O sensitivity to antiretroviral drugs.
    Descamps D; Collin G; Loussert-Ajaka I; Saragosti S; Simon F; Brun-Vézinet F
    AIDS; 1995 Aug; 9(8):977-8. PubMed ID: 7576340
    [No Abstract]   [Full Text] [Related]  

  • 11. Charge modification of plasma and milk proteins results in antiviral active compounds.
    Swart PJ; Harmsen MC; Kuipers ME; Van Dijk AA; Van Der Strate BW; Van Berkel PH; Nuijens JH; Smit C; Witvrouw M; De Clercq E; de Béthune MP; Pauwels R; Meijer DK
    J Pept Sci; 1999 Dec; 5(12):563-76. PubMed ID: 10628656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid screening of antiretroviral combinations.
    St Clair M; Pennington KN; Rooney J; Barry DW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S24-7. PubMed ID: 8595504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by ddCyd and ddIno.
    Ayisi NK
    East Afr Med J; 1995 Oct; 72(10):654-7. PubMed ID: 8904046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against adenovirus.
    Uckun FM; Pendergrass S; Qazi S; Samuel P; Venkatachalam TK
    Eur J Med Chem; 2004 Mar; 39(3):225-34. PubMed ID: 15051170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How to evaluate anti-HIV activity].
    Murakami T; Nakashima H; Yamamoto N
    Nihon Rinsho; 1993 Sep; 51 Suppl():113-9. PubMed ID: 8271373
    [No Abstract]   [Full Text] [Related]  

  • 17. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors.
    Blair WS; Isaacson J; Li X; Cao J; Peng Q; Kong GF; Patick AK
    Antiviral Res; 2005 Feb; 65(2):107-16. PubMed ID: 15708637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antiviral activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil against HIV-1.
    Maruyama T; Kozai S; Demizu Y; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
    Nucleic Acids Symp Ser (Oxf); 2004; (48):3-4. PubMed ID: 17150449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity.
    Campiani G; Nacci V; Fiorini I; De Filippis MP; Garofalo A; Greco G; Novellino E; Altamura S; Di Renzo L
    J Med Chem; 1996 Jul; 39(14):2672-80. PubMed ID: 8709096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and antiviral evaluations of 1-(substituted benzyl)-2-substituted-5,6-dichlorobenzimidazoles as nonnucleoside analogues of 2,5,6-trichloro-1-(beta-D-ribofuranosyl)benzimidazole.
    Porcari AR; Devivar RV; Kucera LS; Drach JC; Townsend LB
    J Med Chem; 1998 Apr; 41(8):1252-62. PubMed ID: 9548815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.